Skip to main content
Vaxil Bio Ltd. logo

Vaxil Bio Ltd. — Investor Relations & Filings

Ticker · VXL TSXV Professional, scientific and technical activities
Filings indexed 116 across all filing types
Latest filing 2023-03-30 Regulatory Filings
Country CA Canada
Listing TSXV VXL

About Vaxil Bio Ltd.

http://vaxil-bio.com

Vaxil Bio Ltd. is a biotechnology company focused on developing novel immunotherapies and targeted therapies. The company utilizes a proprietary drug discovery and development platform centered on Signal Peptides (SPs). This platform leverages signal peptide domains found on specific proteins to create targeted treatments. Vaxil's pipeline includes neoantigen-like peptide products and antibodies designed to address significant unmet medical needs in both cancer (immuno-oncology) and infectious diseases.

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
Regulatory Filings
2023-03-30 English
Form of proxy - English.pdf
Regulatory Filings
2023-03-30 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2023-03-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-11-21 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-11-21 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-11-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.